World Of Taxonomy
31722-779Level 3

Nilotinib (Nilotinib)

**Product type:** Human Prescription Drug

**Active ingredient:** NILOTINIB

**Strength:** 150 mg/1

**Dosage form:** Capsule

**Route:** Oral

**Labeler:** Camber Pharmaceuticals, Inc.

**Marketing category:** ANDA (ANDA209651)

**Pharmacologic class:** Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA], UGT1A1 Inhibitors [MoA]

GET/api/v1/systems/ndc_fda/nodes/31722-779
Official DownloadPublic Domain (US Government)Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.

31722-779 - Nilotinib (Nilotinib) - NDC - World Of Taxonomy | World Of Taxonomy